By: Kairos Ventures On: September 23, 2019 In: Foldax, Portfolio News

Foldax, Inc. announced its first-in-human use of the Tria heart valve under its FDA Early Feasibility Study (EFS) for...

Read more
By: Kairos Ventures On: February 27, 2019 In: Foldax, Portfolio News

Kairos Ventures portfolio company Foldax Inc. announced the U.S. Food and Drug Administration (FDA) has granted investigative device exemption...

Read more
By: Kairos Ventures On: August 31, 2015 In: Foldax, Portfolio News

We are excited to announce that Foldax is the latest company to join our portfolio, following our investment in...

Read more